A Glasmacher

Author PubWeight™ 42.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. Leukemia 2004 2.08
2 Clostridium difficile infection in patients with neutropenia. Clin Infect Dis 2001 2.00
3 Evaluation of an ultrasound-guided technique for central venous access via the internal jugular vein in 493 patients. Support Care Cancer 2002 1.95
4 High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia 2005 1.72
5 Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine. Br J Cancer 2003 1.57
6 Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield. Leukemia 2007 1.28
7 Diagnosis of invasive fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003 1.21
8 Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis 2004 1.18
9 Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis. Leukemia 2012 1.07
10 Pseudomonas aeruginosa outbreak in a haematology-oncology unit associated with contaminated surface cleaning equipment. J Hosp Infect 2002 1.06
11 Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells. Haematologica 2001 1.02
12 Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography. Anticancer Res 2005 1.01
13 Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study. Neurology 2005 0.99
14 Bisphosphonates in multiple myeloma. Cochrane Database Syst Rev 2002 0.97
15 Early versus deferred treatment for early stage multiple myeloma. Cochrane Database Syst Rev 2003 0.96
16 Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients. Ann Hematol 2003 0.95
17 Pulmonary infiltrates in neutropenic patients with acute leukemia during chemotherapy: outcome and prognostic factors. Chest 1998 0.94
18 Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance. Cancer Genet Cytogenet 2006 0.92
19 MR imaging of pneumonia in immunocompromised patients: comparison with helical CT. AJR Am J Roentgenol 2000 0.91
20 Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial. Leukemia 2006 0.91
21 The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma. Br J Cancer 2004 0.88
22 Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AML. Ann Hematol 1999 0.87
23 False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem? J Antimicrob Chemother 2008 0.86
24 Geotrichum capitatum septicaemia in neutropenic patients: case report and review of the literature. Mycoses 1998 0.86
25 Low frequency of enteric infections by Salmonella, Shigella, Yersinia and Campylobacter in patients with acute leukemia. Infection 2002 0.81
26 Autoimmune neutropenia due to NA1 specific antibodies in primary biliary cirrhosis. Br J Haematol 1991 0.81
27 An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant? Infection 2008 0.81
28 Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer. Cancer Treat Rev 2005 0.79
29 Severe abdominal infections in neutropenic patients. Cancer Invest 2001 0.79
30 Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma. Clin Cancer Res 2001 0.79
31 Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies. Support Care Cancer 2006 0.79
32 Protecting vulnerable groups in the home: the interface between institutions and the domestic setting. J Infect 2001 0.79
33 [Diagnosis of systemic fungal infections in hematology. Standard recommendations of the Working Group for Infections in Hematology and Oncology of the German Association for Hematology and Oncology]. Dtsch Med Wochenschr 1999 0.78
34 In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy. Br J Haematol 2006 0.78
35 Bisphosphonates in multiple myeloma. Cochrane Database Syst Rev 2001 0.78
36 Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison. Support Care Cancer 2003 0.78
37 Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines. Leukemia 1996 0.77
38 Increased sensitivity of myeloid leukemia cell lines: potential of lovastatin as bone-marrow-purging agent. Acta Haematol 2000 0.77
39 Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study. J Neurol Neurosurg Psychiatry 2001 0.77
40 Topoisomerase II activities in AML and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines. Leukemia 1996 0.77
41 Tigecycline in febrile neutropenic patients with haematological malignancies: a retrospective case documentation in four university hospitals. Infection 2013 0.76
42 Weekly docetaxel in patients with pretreated metastatic breast cancer: a phase II trial. Anticancer Drugs 2003 0.76
43 Thalidomide in multiple myeloma. Curr Pharm Biotechnol 2006 0.75
44 Impact of portable air filtration units on exposure of haematology-oncology patients to airborne Aspergillus fumigatus spores under field conditions. J Hosp Infect 2003 0.75
45 [Pro and contra adjuvant chemotherapy in colorectal carcinoma]. Med Klin (Munich) 1996 0.75
46 [Primary non-Hodgkin lymphoma of the ovary]. Aktuelle Radiol 1998 0.75
47 [The typical radiological findings and course of invasive pulmonary aspergillosis in the immunosuppressed patient]. Rofo 1997 0.75
48 Small bowel obstruction in acute myelogenous leukemia: stenosis or paralysis? Ann Hematol 2001 0.75
49 Primary central nervous system lymphoma: a clinicopathological study of 28 cases. Hematol Oncol 2000 0.75
50 [Aftercare in patients with colorectal carcinomas]. Dtsch Med Wochenschr 1995 0.75
51 Topoisomerase activities in undifferentiated acute myeloblastic leukemias and monocytic differentiated leukemias. Recent Results Cancer Res 1997 0.75
52 [MRT versus CT in the diagnosis of pneumonias: an evaluation of a T2-weighted ultrafast turbo-spin-echo sequence (UTSE)]. Rofo 1999 0.75
53 Successful induction and consolidation therapy of acute myeloid leukaemia in a renal allograft recipient. Nephrol Dial Transplant 1997 0.75
54 Acute myeloid leukemia with near-triploid karyotype and extramedullary involvement of mediastinum. Bone Marrow Transplant 2005 0.75
55 [Libyan patient with chronic diarrhea]. Z Gastroenterol 1996 0.75
56 Azacitidine access program for Belgian patients with myelodysplastic syndromes, acute myeloid leukemia or chronic myelomonocytic leukemia. Curr Med Res Opin 2014 0.75
57 [Pharmacokinetics of colloidal bismuth subcitrate. Solution versus tablet]. Arzneimittelforschung 1993 0.75